6TVO
Human CRM1-RanGTP in complex with Leptomycin B
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PETRA III, EMBL c/o DESY BEAMLINE P14 (MX2) |
Synchrotron site | PETRA III, EMBL c/o DESY |
Beamline | P14 (MX2) |
Temperature [K] | 180 |
Detector technology | PIXEL |
Collection date | 2017-10-24 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.97630 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 122.290, 151.330, 234.843 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 73.910 - 3.201 |
R-factor | 0.2169 |
Rwork | 0.216 |
R-free | 0.23540 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3nc1 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX (V1.15) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 73.910 | 73.910 | 3.390 |
High resolution limit [Å] | 3.200 | 9.560 | 3.200 |
Rmerge | 0.058 | 0.016 | 0.902 |
Rmeas | 0.065 | 0.018 | 1.014 |
Total number of observations | 173383 | ||
Number of reflections | 36131 | 1464 | 5638 |
<I/σ(I)> | 17.63 | 71.05 | 1.96 |
Completeness [%] | 99.5 | 98.9 | 98.8 |
Redundancy | 4.799 | 4.426 | 4.885 |
CC(1/2) | 0.999 | 0.999 | 0.749 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 277.15 | 0.02M sodium L-glutamate, 0.02M DL-alanine, 0.02M glycine, 0.02M DL-lysine HCl, 0.02 M DL-serine, 10%w/v PEG 8000, 20% v/v ethylene glycol, 0.1M bicine /Trizma base pH 8.5 |